A case of hepatitis B virus and hepatitis C virus co-infection that achieved sustained virological response 12 following treatment with glecaprevir hydrate/pibrentasvir for 3 days-Reference-Cited by-同舟云学术

A case of hepatitis B virus and hepatitis C virus co-infection that achieved sustained virological response 12 following treatment with glecaprevir hydrate/pibrentasvir for 3 days

Published:2021-09-01 Issue:9 Volume:62 Page:578-584
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Numata Yasunao¹,Sasaki Shigeru¹,Akutsu Noriyuki¹,Hirano Takehiro¹,Wagatsuma Kohei¹,Kawakami Yujiro¹,Ishigami Keisuke¹,Nakase Hiroshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/62/9/62_578/_pdf

Reference26 articles.

1. 1) Toyoda H, Chayama K, Suzuki F, et al. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection. Hepatology 2018; 67: 505-513

2. 2) Chayama K, Suzuki F, Karino Y, et al. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis. Journal of Gastroenterology 2017; 53: 557-565

3. 3) 森仁志, 高谷広章, 浪崎正, 他. 直接作用型抗ウイルス薬治療中に肝予備能が低下し, 治療中止となるも持続性ウイルス学的著効が得られたC型肝硬変の1例. 日本消化器病学会雑誌 2018; 115: 476-484

4. 4) 高岡良成, 森本直樹, 渡邊俊司, 他. 12日間のダクラタスビル, アスナプレビル併用療法でSVRを達成した腎移植後のC型慢性肝炎の1例. 自治医科大学紀要 2017; 39: 29-32

5. 5) Meissner EG, Nelson A, Marti M, et al. Sustained Virologic Response for Chronic Hepatitis C Infection after 27 Days of Treatment with Sofosbuvir and Ribavirin. Open Forum Infect Dis 2014; 1: 013